NOT-DA-10-012: Second Notice to Clarify Other Submission Requirements for the 2010 NIDA Translational Avant-Garde Award for Medication Development for Diseases of Addiction, PAR-10-095

Second Notice to Clarify Other Submission Requirements for the 2010 NIDA Translational Avant-Garde Award for Medication Development for Diseases of Addiction, PAR-10-095

Notice Number: NOT-DA-10-012

Key Dates
Release Date: February 19, 2010

Issued by
National Institute on Drug Abuse (NIDA), (http://www.nida.nih.gov)

Purpose

The purpose of this Notice is to clarify language in Section IV.6. Other Submission Requirements of the Pre-Application for the 2010 NIDA Translational Avant-Garde Award for Medication Development for Diseases of Addiction (X02), PAR-10-095 (http://grants.nih.gov/grants/guide/pa-files/PAR-10-095.html).

Specifically,

Section IV.6.1 SF424 (R&R) Cover Component: Item Number 12. Proposed Project: should read

Start date: 09/30/2010; End date: 09/29/2015.

Section IV.6.3 Research & RELATED Other Project Information Component, Item Number 7. Project Summary/Abstract: should read

Attach a one page (maximum) abstract describing the goals of the projects. Text only, in PDF format – no figures, animations, or Web links are allowed.

Other sections of the FOAs remain unchanged.

Inquiries

For further information contact:

Elena Koustova, Ph.D.
Division of Basic Neuroscience and Behavioral Research
National Institute on Drug Abuse
National Institutes of Health
6001 Executive Blvd
Rm 4282 MSC 9555
Bethesda, MD 20892
Telephone: 301-496-8768
Fax: 301-594-6043
Email: [email protected]

Nora Chiang, Ph.D.
Division of Pharmacotherapies and Medical Consequences of Drug Abuse
Chemistry and Pharmaceutics Branch
National Institute on Drug Abuse
National Institutes of Health
6001 Executive Blvd
Rm 4123 MSC 9551
Bethesda, MD 20892
Telephone: 301-443-5280
Email: [email protected]